Cannabinoid science has opened the door to the development of FDA-approved plant-derived cannabinoid medications that are used to treat a number of neurological diseases. Over more than two decades, teams at Jazz have established a world-leading cannabinoid science platform to develop a deep, innovative pipeline of early and late-stage cannabinoid product candidates and highly specialized growing and manufacturing expertise.
Through these committed efforts, GW Pharmaceuticals, part of Jazz Pharmaceuticals, developed and commercialized the world’s first prescription medicine derived from the cannabis plant. Unlike non-FDA-approved cannabidiol products or cannabis-derived products, our regulatory-approved portfolio ensures that every product manufactured has a safety and efficacy profile that has been thoroughly evaluated in clinical trials, independently peer-reviewed, approved by regulatory authorities (FDA, MHRA, etc.), and consistently manufactured to ensure the highest quality standards are met. To learn more about the difference between FDA-approved and non-FDA-approved cannabinoid products, please visit https://www.cannabinoidclinical.com/™.
Building on the success as a pioneer in this emerging treatment area, teams at Jazz continue to trailblaze to enable the development, manufacture, and commercialization of regulatory approved cannabinoid medicines with the potential to transform the lives of patients and their families.
Teams at Jazz have pioneered advancements in cannabinoid science to realize the therapeutic and breakthrough potential of cannabinoid medicines. Through our work to deliver regulatory-approved medicines in this new frontier of science, we have advanced the understanding how cannabinoids can revolutionize the way patients manage often-overlooked diseases, while redefining what living with their disease or condition means.
Cannabinoids interact with many neurotransmitter and neuromodulator systems in the human body, offering the potential to meet currently unmet needs of patients in multiple treatment areas.
At Jazz, we seek solutions for rare or complex diseases, and work to make those solutions available to the often-overlooked patients who need them. In 2021, we acquired GW Pharmaceuticals and integrated two teams with a shared vision of bringing patients and healthcare professionals innovative and differentiated therapies that advance science and help people lead fuller lives.
We are the first and only company to receive a U.S. Food and Drug Administration (FDA) approval for a plant-derived cannabinoid medicine, and our teams bring deep scientific understanding of the pharmacological effects, unique formulation, rigorous clinical testing and regulated manufacturing process of this growing treatment category.
With a heritage in cannabinoid science and research, Jazz is focused on driving positive impact for patients, caregivers and healthcare providers to realize further benefit from our cannabinoid-based medicines.
Teams at Jazz have highly specialized expertise in growing and manufacturing regulatory approved cannabinoid medicines, developed over two decades of pioneering and building leadership in cannabinoid science.
Our manufacturing facilities and processes are compliant with Good Agricultural Practices and Good Manufacturing Practices. Our scientists control all aspects of the plant growing cycle and plants are grown in a controlled, pesticide and contaminant-free environment before they are processed, stored and continually quality tested. All our products are quality tested after purification and formulation to ensure quality and consistency at every step of the manufacturing process.
This page is intended for U.S. residents only. We are not accepting requests from individuals in states other than California, Washington and Nevada. If you are not a resident of any of these states, please do NOT continue.
Please select and enter the required fields on the form below. We need this information to process your request and to take necessary steps to verify your identity. We will contact you if we need any additional information.
Please note that your rights may vary under applicable state privacy laws and may be subject to limitations.
